Watch: Allergan, Pfizer call off proposed $160B merger

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.

Must watch video

NZ Herald Focus video

Entertainment video

Lifestyle video

National video

World video

Business video